Influenza and myocardial infarction

References

• Alber DG, Powell KL, Vallance P, Goodwin DA, Grahame-Clarke C. Herpes virus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation102(7), 779–785 (2000).
   PubMed Web of Science ®Google Scholar
• Bjorkbacka H, Kunjathoor VV, Moore KJ et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med.10(4), 416–421 (2004).
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med.340(2), 115–126 (1999).
   PubMed Web of Science ®Google Scholar
• Danesh J, Whincup P, Walker M et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br. Med. J.321(7255), 199–204 (2000).
   PubMed Web of Science ®Google Scholar
• Danesh J, Wheeler JG, Hirschfield GM et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med.350(14), 1387–1397 (2004).
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA296(14), 1735–1741 (2006).
   PubMed Web of Science ®Google Scholar
• Watson DJ, Rhodes T, Guess HA. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J. Rheumatol.30(6), 1196–1202 (2003).
   PubMed Web of Science ®Google Scholar
• Hingorani AD, Cross J, Kharbanda RK et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation102(9), 994–999 (2000).
   PubMed Web of Science ®Google Scholar
• Kharbanda RK, Walton B, Allen M et al. Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin. Circulation105(22), 2600–2604 (2002).
   PubMed Web of Science ®Google Scholar
• Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N. Engl. J. Med.351(25), 2611–2618 (2004).
   PubMed Web of Science ®Google Scholar
• Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol. Infect.110(1), 145–160 (1993).
   PubMed Web of Science ®Google Scholar
• Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect. Dis.9(10), 601–610 (2009).
   PubMed Web of Science ®Google Scholar
• Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: case–control study through a general practice database. Eur. Heart J.29(1), 96–103 (2008).
   PubMed Web of Science ®Google Scholar
• Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet351(9114), 1467–1471 (1998).
   PubMed Web of Science ®Google Scholar
• Chi CY, Wang SM, Lin CC et al. Clinical features of children infected with different strains of influenza B in southern Taiwan. Pediatr. Infect. Dis. J.27(7), 640–645 (2008).
   PubMed Web of Science ®Google Scholar
• Bishop JF, Murnane MP, Owen R. Australia’s winter with the 2009 pandemic influenza A (H1N1) virus. N. Engl. J. Med.361(27), 2591–2594 (2009).
   PubMed Web of Science ®Google Scholar
• Cretikos MA, Muscatello DJ, Patterson J. Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. Euro. Surveill.14(42), article 6 (2009).
   Google Scholar
• Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro. Surveill.14(33), pii19309 (2009).
   Google Scholar
• Szretter KJ, Gangappa S, Lu X et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J. Virol.81(6), 2736–2744 (2007).
   PubMed Web of Science ®Google Scholar
• Keller TT, van der Sluijs KF, de Kruif MD et al. Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Circ. Res.99(11), 1261–1269 (2006).
   PubMed Web of Science ®Google Scholar
• Muramoto Y, Ozaki H, Takada A et al. Highly pathogenic H5N1 influenza virus causes coagulopathy in chickens. Microbiol. Immunol.50(1), 73–81 (2006).
   PubMed Web of Science ®Google Scholar
• Garcia-Moll X. Influenza vaccination: a new indication of an old therapy? Rev. Esp. Cardiol.56(10), 944–946 (2003).
   PubMed Web of Science ®Google Scholar
• Di Stefano R, Di Bello V, Barsotti MC et al. Inflammatory markers and cardiac function in acute coronary syndrome: Difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models. Biomed. Pharmacother.63(10), 773–780 (2009).
   PubMed Web of Science ®Google Scholar
• Hamer M, Chida Y, Stamatakis E. Association of very highly elevated C-reactive protein concentration with cardiovascular events and all-cause mortality. Clin. Chem.56(1), 132–135 (2009).
   PubMed Web of Science ®Google Scholar
• Shah T, Casas JP, Cooper JA et al. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int. J. Epidemiol.38(1), 217–231 (2009).
   PubMed Web of Science ®Google Scholar
• Helfand M, Buckley DI, Freeman M et al. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann. Intern. Med.151(7), 496–507 (2009).
   PubMed Web of Science ®Google Scholar
• Ciszewski A, Bilinska ZT, Brydak LB et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur. Heart J.29(11), 1350–1358 (2008).
   PubMed Web of Science ®Google Scholar
• Gurfinkel EP, Leon de la FR, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur. Heart J.25(1), 25–31 (2004).
   PubMed Web of Science ®Google Scholar
• Baigent C, Keech A, Kearney PM et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet366(9493), 1267–1278 (2005).
   PubMed Web of Science ®Google Scholar
• Hayward A. Influenza A (H1N1) pandemic: true or false alarm. J. Epidemiol. Community Health63(10), 775–776 (2009).
   PubMed Web of Science ®Google Scholar
• Enger C, Nordstrom BL, Thakrar B, Sacks S, Rothman KJ. Health outcomes among patients receiving oseltamivir. Pharmacoepidemiol. Drug Saf.13(4), 227–237 (2004).
   PubMed Web of Science ®Google Scholar
• Ward Casscells S, Granger E, Kress AM, Linton A, Madjid M, Cottrell L. Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases. Circ. Cardiovasc. Qual. Outcomes2, 108–115 (2009).
   PubMed Web of Science ®Google Scholar
• Paciaroni M, Bogousslavsky J. Statins and stroke prevention. Expert Rev. Cardiovasc. Ther.7(10), 1231–1243 (2009).
   PubMedGoogle Scholar
• Tuttolomondo A, Di Sciacca R, Di Raimondo D et al. Inflammation as a therapeutic target in acute ischemic stroke treatment. Curr. Top. Med. Chem.9(14), 1240–1260 (2009).
   PubMed Web of Science ®Google Scholar
• Frost FJ, Petersen H, Tollestrup K, Skipper B. Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest131(4), 1006–1012 (2007).
   PubMed Web of Science ®Google Scholar
• Tleyjeh IM, Kashour T, Hakim FA et al. Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch. Intern. Med.169(18), 1658–1667 (2009).
   PubMed Web of Science ®Google Scholar